Technological Innovation and Digital Transformation in the Mesenchymal Stem Cell and Exosome Diagnostics and Therapies Market
The regenerative medicine industry is experiencing a technological renaissance, driven by advances in cell biology, exosome science, and artificial intelligence. The Mesenchymal Stem Cell and Exosome Diagnostics and Therapies Market is at the forefront of these innovations, valued at USD 6.6 billion in 2025 and projected to reach USD 15 billion by 2035 at a CAGR of 8.6%. This article...
0 Commentarios 0 Acciones 149 Views 0 Vista previa